POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AVP_A_MV2A313_1 (PANTOTHENATE KINASE)	3kq4	GASTRIC INTRINSIC FACTOR (Homo sapiens)	4 / 7	VAL A 346 LEU A 347 ILE A 333 ASN A 334	None	1.03A	19.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AVP_A_MV2A313_1 (PANTOTHENATE KINASE)	3nwu	SERINE PROTEASE HTRA1 (Homo sapiens)	4 / 7	VAL A 221 HIS A 185 ILE A 342 ASN A 218	None None None SO4  A   1 (-3.0A)	1.06A	19.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AVP_A_MV2A313_1 (PANTOTHENATE KINASE)	3zg6	NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-6 (Homo sapiens)	4 / 7	VAL A 259 HIS A 266 LEU A  28 ILE A 209	None	1.00A	23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AVP_A_MV2A313_1 (PANTOTHENATE KINASE)	4nhy	2-OXOGLUTARATE AND IRON-DEPENDENT OXYGENASE DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 7	VAL A 197 ASP A  57 HIS A  63 ILE A 187	None	0.96A	20.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AVP_A_MV2A313_1 (PANTOTHENATE KINASE)	4rxx	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 38 (Homo sapiens)	4 / 7	VAL A  60 ASP A  54 LEU A  48 ILE A  21	None	1.05A	21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AVP_A_MV2A313_1 (PANTOTHENATE KINASE)	4yub	NICOTINATE PHOSPHORIBOSYLTRANSF ERASE (Homo sapiens)	4 / 7	ASP A 288 HIS A 213 LEU A 324 ILE A 358	None	1.02A	21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AVP_A_MV2A313_1 (PANTOTHENATE KINASE)	4ywg	HEAVY CHAIN OF ANTI-HIV-1 GP120 V1V2 ANTIBODY 830A (Homo sapiens)	4 / 7	VAL H  24 ASP H 101 LEU H   4 ILE H  71	None	0.89A	20.62